<div id="readability-page-1">Looking for top-rated stocks to buy now? Based on recent analyst updates, the three companies below have all earned Strong Buy ratings from Top Wall Street Analysts. Each offers meaningful upside potential, backed by new Buy calls.<h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. </li><li> Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off </li></ul> For more ideas, you can explore TipRanks' Analyst Top Stocks tool, which tracks the latest Buy ratings from top-performing analysts in real time. Here are today's top stock picks, according to analysts. Click on any ticker to thoroughly research the stock before you decide whether to add it to your portfolio. <ul> <li>Tenaya Therapeutics (TNYA) – This is a clinical-stage biotech focused on developing gene and cell therapies for rare and inherited heart diseases. Today, William Blair analyst Sami Corwin maintained a Buy rating on the stock. In the last three months, all six Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 826.5%. </li> <li>Evolv Technologies (EVLV) – Evolv Technologies builds AI tools that help spot weapons at schools, stadiums, and other public sites. Today, Craig-Hallum analyst Jeremy Hamblin maintained a Buy rating on the stock with a price target of $275 per share. In the last three months, all four Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 44.44%. </li> <li>Aardvark Therapeutics (AARD) – This is a biotech firm developing oral drugs that target hunger signals to help treat obesity and related metabolic conditions. Today, William Blair analyst Andy Hsieh initiated coverage on the stock. In the last three months, all seven Top Analysts covering the stock have rated it a Buy. Taken together, their 12-month price targets imply an upside of about 101.35%.</li> </ul> <h2>Who Are the Top Analysts? </h2> TipRanks ranks financial analysts according to the success rates of their ratings and the average return on each of their ratings. The Top Analysts have each earned a five-star ranking, thanks to the accuracy and profitability of their ratings over time. See real-time analyst rankings and learn more about the performance of Top Analysts on TipRanks' Top Wall Street Analysts page. </div>

TNYA

EVLV

AARD

Top Wall Street analysts have given 'Strong Buy' ratings to three stocks: Tenaya Therapeutics (TNYA), Evolv Technologies (EVLV), and Aardvark Therapeutics (AARD). Tenaya Therapeutics focuses on gene and cell therapies for heart diseases, with an implied upside of 826.5%. Evolv Technologies develops AI tools for weapon detection, with an implied upside of 44.44%. Aardvark Therapeutics targets obesity treatments, with an implied upside of 101.35%.

3 'Strong Buy' Stocks to Buy Today, 12/12/2025, According to Top Analysts